propranolol has been researched along with Cardiotoxicity in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiogenic shock was induced in healthy pigs with a bolus of 0." | 1.56 | Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning. ( Cole, JB; Corcoran, JN; Engebretsen, KM; Stellpflug, SJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, RMSM | 1 |
| Ahmad, EA | 1 |
| Omran, BHF | 1 |
| Sakr, AT | 1 |
| Ibrahim, IAAE | 1 |
| Mahmoud, MF | 1 |
| El-Naggar, ME | 1 |
| Shen, X | 1 |
| Zhi, F | 1 |
| Shi, C | 1 |
| Xu, J | 2 |
| Chao, Y | 1 |
| Jiang, Y | 1 |
| Bai, Y | 1 |
| Yang, B | 1 |
| Cole, JB | 1 |
| Corcoran, JN | 1 |
| Engebretsen, KM | 1 |
| Stellpflug, SJ | 1 |
| Arai, K | 1 |
| Murata, D | 1 |
| Takao, S | 1 |
| Nakamura, A | 1 |
| Itoh, M | 1 |
| Kitsuka, T | 1 |
| Nakayama, K | 1 |
4 other studies available for propranolol and Cardiotoxicity
| Article | Year |
|---|---|
Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiotoxicity; Carvedilol; Dexamethasone; Phenyle | 2022 |
The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity.
Topics: Animals; Apoptosis; Arsenic Trioxide; Cardiotoxicity; Mice; MicroRNAs; Propranolol; RNA, Long Noncod | 2023 |
Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotoxicity; Disease Models, Animal; Drug Administration Sc | 2020 |
Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer.
Topics: Cardiotoxicity; Cell Survival; Doxorubicin; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 | 2020 |